institutional-investors

DNA

Biotech Bonanza: Is Ginkgo Bioworks Setting the Stage for a DNA Revolution?

Could Ginkgo Bioworks Holdings be the next big thing in biotech? With nearly half of its stock in institutional hands, this is worth a look!